Vanderbilt University Med Ctr /ID# 162916 — Nashville, Tennessee

Vanderbilt University Med Ctr /ID# 162916 is a clinical research site located in Nashville, Tennessee, United States 37232-6307.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Vanderbilt University Med Ctr /ID# 162916 has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vanderbilt University Med Ctr /ID# 162916?

Vanderbilt University Med Ctr /ID# 162916 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vanderbilt University Med Ctr /ID# 162916 conducted?

Vanderbilt University Med Ctr /ID# 162916 has 1 clinical trials on record. Their work covers Small Cell Lung Cancer.

Is Vanderbilt University Med Ctr /ID# 162916 accredited by Crixeo Health?

Vanderbilt University Med Ctr /ID# 162916 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vanderbilt University Med Ctr /ID# 162916?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.